Document ID: chunk:federal_register_of_legislation:F2019L01096:reg:9:p3
Version: federal_register_of_legislation:F2019L01096
Segment Type: reg
Provision Reference: reg 9 (pt 3/4)
Character Range: 9394–12237

the clinical onset of malignant neoplasm of the bladder;
Note: working as a hairdresser or barber is defined in the Schedule 1 – Dictionary.
(13)      working as a painter for a cumulative period of at least 5 000 hours before the clinical onset of malignant neoplasm of the bladder, where that work began at least five years before the clinical onset of malignant neoplasm of the bladder;
Note: working as a painter is defined in the Schedule 1 – Dictionary.
(14)      having renal stone disease or a bladder stone at least five years before the clinical onset of malignant neoplasm of the bladder;
(15)      having chronic renal failure at least one year before the clinical onset of malignant neoplasm of the bladder;
Note: chronic renal failure is defined in the Schedule 1 – Dictionary.
(16)      having an infection of the bladder with Schistosoma haematobium at least five years before the clinical onset of malignant neoplasm of the bladder;
(17)      having an indwelling bladder catheter or other foreign body in the bladder for a continuous period (excepting routine catheter changes) of at least five years, before the clinical onset of malignant neoplasm of the bladder;
(18)      having neurogenic bladder at least five years before the clinical onset of malignant neoplasm of the bladder;
Note: neurogenic bladder is defined in the Schedule 1 – Dictionary.
(19)      having chronic urinary tract infection at least five years before the clinical onset of malignant neoplasm of the bladder;
Note: chronic urinary tract infection is defined in the Schedule 1 – Dictionary.
(20)      having diabetes mellitus for at least five years before the clinical onset of malignant neoplasm of the bladder;
(21)      having benign prostatic hyperplasia at least five years before the clinical onset of malignant neoplasm of the bladder;
(22)      ingesting aristolochic acid as specified at least two years before the clinical onset of malignant neoplasm of the bladder;
Note: ingesting aristolochic acid as specified is defined in the Schedule 1 – Dictionary.
(23)      consuming a total of at least 100 grams of phenacetin at least five years before the clinical onset of malignant neoplasm of the bladder;
Note: phenacetin is defined in the Schedule 1 – Dictionary.
(24)      being treated with systemic cyclophosphamide or systemic ifosfamide, at least five years before the clinical onset of malignant neoplasm of the bladder;
(25)      being treated with chlornaphazine at least five years before the clinical onset of malignant neoplasm of the bladder;
(26)      being treated with pioglitazone, or a medication containing pioglitazone, for a continuous period of at least one year, within the ten years before the clinical onset of malignant neoplasm of the bladder;
(27)      taking opium on average at least weekly for at least ten